Posted by Michael Wonder on 06 Jan 2024
Health Canada approves Pfizer's bivalent respiratory syncytial virus vaccine for older adults and infants through maternal immunisation
4 January 2024 - Abrysvo is the only RSV vaccine authorised in Canada for maternal immunisation.
Pfizer Canada announces today the Health Canada approval of Abrysvo, its bivalent respiratory syncytial virus vaccine.
